Sio Gene Therapies Inc (SIOX) Stock

DelistedNasdaq: SIOXSio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases.

0.41
Final close · Mar 22, 2023

SIOX is no longer traded. Sio Gene Therapies was delisted from the Nasdaq in March 2023.

Prices on this page are historical; the last trade was March 22, 2023 at $0.41.

Sio Gene Therapies stock price history

Split-adjusted closes, 2015–2023

SIOX final trading statistics

Final close
$0.41
Final trading day
Mar 22, 2023
Market cap at delisting
$30.70M
Shares outstanding
73.98M
Final 52-week range
$0.23 – $0.75
Avg. volume (final 3 mo.)
566,724
All-time high (split-adj.)
$239.20 · Jun 2015
All-time low (split-adj.)
$0.25 · May 2022
Return since IPO
-99.8%
Beta
1.08
Book value / share
$0.61
Price / book
0.68
Final 52 wk
0.230.75

Sio Gene Therapies earnings per share

Earnings per share

Sio Gene Therapies revenue & net income

RevenueNet income

Sio Gene Therapies annual financials

Sio Gene Therapies Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$0.00-$71.9M-$0.98
FY2021$0.00-$32.4M-$0.66
FY2020$0.00-$72.6M-$3.00
FY2019$0.00-$129.1M-$8.69
FY2018$0.00-$221.6M-$16.48

Last five fiscal years reported before the delisting; fiscal year ending March. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Sio Gene Therapies Inc

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Sio Gene Therapies stock FAQ

What happened to Sio Gene Therapies stock?

Sio Gene Therapies stock was delisted from the Nasdaq. Its final close was $0.41 on March 22, 2023.

Is SIOX stock still trading?

No. SIOX was delisted from the Nasdaq in March 2023 and no longer trades on a U.S. exchange.

What was the last price of SIOX stock?

SIOX closed at $0.41 on its final trading day, March 22, 2023, for a market value of about $30.70M.

What were Sio Gene Therapies's revenue and earnings in its last full fiscal year?

Sio Gene Therapies reported revenue of $0.00 and net income of -$71.9M in fiscal 2022, its last full year as a public company.

When did Sio Gene Therapies go public?

Sio Gene Therapies Inc stock began trading on June 11, 2015.

Biotechnology stocks to research

All Healthcare stocks →